about
Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinomaClinical application of 3D-printed-step-bolus in post-total-mastectomy electron conformal therapy.Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinomaThe Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats.Helical tomotherapy for spine oligometastases from gastrointestinal malignanciesClinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.Radiosensitizers in hepatocellular carcinoma.High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma.Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy.Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.Dose escalation using helical tomotherapy improves local control in spine metastases from primary hepatic malignancies.Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomesPrognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive ChemoradiotherapyThe Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with RadiotherapyRisk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancerEvaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiationEvaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapyRadiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinomaSelection of the optimal radiotherapy technique for locally advanced hepatocellular carcinomaA Feasibility Study of a Tilted Head Position in Helical Tomotherapy for Fractionated Stereotactic Radiotherapy of Intracranial MalignanciesImproved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinomaRedefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving TreatmentRisk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective
P50
Q33409555-DEAAEAC9-EF83-4ED6-9D09-576C209B99D8Q33648988-67B1DBE9-AF9F-4850-9DB8-0A1D3107B584Q34384265-F07A2142-34DC-4C95-B3EA-A0EA7C033E0AQ36003252-156B6DDE-0C78-41E9-879A-EFD972A910AEQ36070632-697ED1CC-15DF-4CE5-8CD9-316639776FE7Q36196005-7FABD12D-AEFB-448B-BAA2-88C6146243D4Q36482535-BAF2AE69-D215-4DED-A561-160223470BFCQ37297239-1DDF4670-1C4D-45C2-B2D3-60DF8B956DE0Q37458034-BA84F7D7-F334-4542-80E2-44FA92EC81BCQ37937163-6B25100C-6DD1-4C37-8B5E-EEA9C243A3EFQ42199538-F39C416A-2B60-494B-9F64-CBD87F1FF15EQ43780887-DD12C8CA-84B3-40E4-8293-F7EAE29F7A36Q44801578-3A8671C5-FB85-4C11-A80C-14C1305272B7Q48204961-F9346ED9-EF86-42F0-9A73-B018EEC7F4C2Q53101481-273AE26B-B854-4902-B2F9-C09699D958C8Q53167805-92ED057F-03A3-4693-8E0B-FA4F0D302E28Q53225226-8A249E10-0086-4166-AC38-FE7DA9F92AA5Q54483552-20A9D9FA-E2D8-4448-9DFE-52481DDA0A93Q55283705-2B41400C-8831-4985-8E87-0B90AE4A553BQ59126436-EABF6E8D-84DD-40AC-89A7-485A16E810D7Q59127762-BFA93CC9-FDAA-4157-841B-33AE448C7B76Q60920889-7AFC2FBF-1D86-41F4-9B6A-98D4F16E3DC1Q64057102-65F2E59D-C90F-4C39-9644-0910FB9C7C15Q64097182-AA8EB8BA-D4F8-477B-B3A9-667DCD866B0FQ79595674-FBFA6EB8-34C2-4926-B7A6-8E602121D830Q80566525-E9A930DF-6743-45DE-9CB8-DBF0D37CD8A8Q83941412-606DFDFE-09F4-4E0A-907B-7051EE742186Q85895702-C4DBA57D-A500-4D57-9A07-FB8ADFA48442Q87837345-362439FA-9916-46A2-A89E-78117B869D45Q90102485-8FD7D56A-89AF-400B-A747-FBE6A1359234Q92199998-D0FCD310-7D3A-4B4C-B398-C2ECABA52516
P50
description
researcher ORCID ID = 0000-0001-7165-3373
@en
wetenschapper
@nl
name
Ik Jae Lee
@ast
Ik Jae Lee
@en
Ik Jae Lee
@nl
type
label
Ik Jae Lee
@ast
Ik Jae Lee
@en
Ik Jae Lee
@nl
prefLabel
Ik Jae Lee
@ast
Ik Jae Lee
@en
Ik Jae Lee
@nl
P106
P31
P496
0000-0001-7165-3373